home / stock / arch / arch news


ARCH News and Press, Arch Coal Inc. Class A From 01/11/24

Stock Information

Company Name: Arch Coal Inc. Class A
Stock Symbol: ARCH
Market: NYSE
Website: archrsc.com

Menu

ARCH ARCH Quote ARCH Short ARCH News ARCH Articles ARCH Message Board
Get ARCH Alerts

News, Short Squeeze, Breakout and More Instantly...

ARCH - 3 Stocks to Sidestep in 2024 if Democrats Keep the White House

2024-01-11 08:29:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a previous column, I noted that each political party has sectors of the economy that they tend to support more than the opposing party. Furthermore, when Republicans and Democrats are in...

ARCH - Arch Biopartners Receives Health Canada Approval to Conduct Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it has received a No Objection Letter from Health Canada to conduct a Phase II trial for LSALT peptide, targeting...

ARCH - Materials Sector Weekly Round-up: Alpha Metallurgical tops list; Gold Fields at bottom

2024-01-07 07:09:29 ET More on Materials Select Sector SPDR ETF XLB: Materials Dashboard For December XLB: The ETF That Beat The S&P 500 XLB: S&P500 Materials ETF rises in 2023, CE, MLM, ECL among top movers Materials Sector Weekly Round-up: Cabot at ...

ARCH - Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it has received approval in Turkey from the Ministry of Health to proceed with a Phase II trial for LSALT peptide...

ARCH - Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide

TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Kocaeli University Clinical Research Ethics Committee to proceed with a P...

ARCH - Grant of Options to Directors and Officers

TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that its Board of Directors has granted a total of 350,000 stock options to directors and officers pursuant to the Com...

ARCH - Arch Biopartners Submits Application to Health Canada to Conduct the Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide

TORONTO, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has submitted a Clinical Trial Application to Health Canada to obtain permission to proceed with a Phase II trial f...

ARCH - China Plans to Set Up Coal Production Reserve Despite Pledging to Phase Out Dirty Fuels

A Chinese state planner says the country will set up a backup production system for coal production to secure China’s coal supply and stabilize prices despite national plans to begin phasing out coal use in the latter half of the decade. China is one of dozens of countries that pledged t...

ARCH - Arch Resources: Good Valuation And 100% Of Free Cash Flow Being Returned To Shareholders

2023-12-05 15:13:14 ET Summary Arch Resources has seen a strong performance lately due to a rebound in coking coal prices. Q3 financials were slightly weaker compared to Q2, but improvements are expected in Q4 and 2024. The stock is attractively priced, with the free cash flow...

ARCH - Arch Resources Inc. Class A $ARCH Trading Report

2023-11-22 01:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10